PHARMACOLOGICAL INTERACTIONS OF STATINES WITH NON-INSULINAL ANTIDIABETIC AGENTS
Cristian Suárez Cordo, Susana Salzberg, Jorge Alvariñas and 6 more
Revista de la Sociedad Argentina de Diabetes · 2018
doi:10.47196/diab.v51i2.68 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Introduction: dislipemia prevalence in type 2 diabetes is very often, between 35 to 56%; and despite new therapeutic options, statins continue being the drugs of first choice for treatment. Objectives: analyze the possible pharmacological interactions between statins and non-insulin drugs used in type 2 diabetic patients to normalize blood glucose. Inhibition of statins on HMG-CoA is highly selective, so pharmacodynamic interactions are not expected. But regarding pharmacokinetics, there are several levels where interactions with other drugs may occur. Three main levels of pharmacokinetic interactions have been described so far: membrane transporter OATP1B1, cytochrome P450 and absorption.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.